Urea Cycle and Its Control

Urea Cycle

Objectives

After this lecture, you should be able to:

• Describe the pathway of the urea cycle.

• Understand the link between urea synthesis and gluconeogenesis.

• Understand how the urea cycle is regulated, including the roles of specific enzymes and regulatory molecules.

• Understand the effects of the mentioned genetic mutations, and explain the rationale behind their treatment, detailing the biochemical basis of each treatment strategy.

Urea Cycle Overview

• Purpose (Importance):

  • Amino acids contain nitrogen atoms, unlike carbohydrates and fats. The removal and disposal of this nitrogen is crucial for maintaining health.

  • When amino acids are catabolized, nitrogen waste must be safely excreted to prevent toxic buildup in the body.

  • In humans, this requires urea production by the liver, which is then excreted in the urine via the kidneys.

  • The urea cycle is especially important in situations where amino acid catabolism is increased, such as during high-protein diets, starvation, or uncontrolled diabetes, or where there is increased protein turnover due to illness or growth.

  • Note: The urea cycle does NOT operate prenatally; the fetus relies on the mother's urea cycle to dispose of its waste nitrogen.

  • During amino acid catabolism, waste nitrogen is either transferred to keto-acids (for eventual conversion to glucose or fat) or released as highly toxic ammonia. The balance between these two processes is critical.

  • Ammonia in the plasma is normally < $50 \mu mol/L$, and is toxic above $100 \mu mol/L$. Elevated ammonia levels (hyperammonemia) can lead to neurological damage, coma, and death.

• Location:

  • The liver is the only tissue that expresses all the enzymes of the urea cycle, but not in every hepatocyte, leading to metabolic zonation.

  • The periportal hepatocytes (as opposed to perivenous hepatocytes, which are more involved in glutamine synthesis) carry out urea production. This spatial separation prevents constant cycling of ammonia between urea synthesis and glutamine synthesis.

• Steps:

  • The urea cycle involves several enzymes and occurs in both the mitochondria and cytosol:

    • Carbamoyl phosphate synthetase I (CPS1): The first committed step, located in the mitochondrial matrix.

    • Ornithine transcarbamoylase (OTC): Also located in the mitochondrial matrix.

    • Argininosuccinate synthetase (ASS): A cytoplasmic enzyme.

    • Argininosuccinase (ASL): Another cytoplasmic enzyme.

    • Arginase (ARG1): The final enzyme of the cycle, located in the cytoplasm.

Steps of the Urea Cycle in Detail

1. Carbamoyl Phosphate Synthetase I (CPSI):

   • Occurs in the mitochondrial matrix.

   • Absolutely dependent on N-acetylglutamate (NAG) for its activity. NAG is the essential allosteric activator.

   $NH<em>3 + HCO</em>3^- + 2ATP \rightarrow \text{Carbamoyl Phosphate} + 2ADP + Pi$

2. Ornithine Carbamoyltransferase (OTC):

   • Occurs in the mitochondrial matrix.

   • Carbamoyl phosphate reacts with ornithine to form citrulline. Citrulline is then transported to the cytoplasm.

   $\text{Carbamoyl Phosphate} + \text{Ornithine} \rightarrow \text{Citrulline} + Pi$

3. Argininosuccinate Synthetase (ASS):

   • Cytoplasmic enzyme.

   • Citrulline reacts with aspartate to form argininosuccinate. This step requires ATP.

   $\text{Citrulline} + \text{Aspartate} + ATP \rightarrow \text{Argininosuccinate} + AMP + PPi$

4. Argininosuccinase (ASL):

   • Cytoplasmic enzyme.

   • Argininosuccinate is cleaved to form arginine and fumarate.

   $\text{Argininosuccinate} \rightarrow \text{Arginine} + \text{Fumarate}$

5. Arginase (ARG1):

   • Cytoplasmic enzyme.

   • Arginine is cleaved to form urea and ornithine.

   • Ornithine returns to the mitochondrial matrix for another turn of the cycle, thus regenerating the initial substrate.

   $\text{Arginine} + H_2O \rightarrow \text{Urea} + \text{Ornithine}$

Inputs/Outputs of the Urea Cycle

The overall reaction:

$\text{Aspartate} + NH<em>3 + CO</em>2 + 3ATP + H_2O \rightarrow \text{Urea} + \text{Fumarate} + 2ADP + 2Pi + AMP + PPi$

• Inputs:

  • Nitrogen enters the cycle as aspartate and ammonia. These are the primary sources of nitrogen that will be incorporated into urea.

  • Ammonia predominantly comes from glutamate or glutamine, via glutamate dehydrogenase or glutaminase, respectively. Glutamate dehydrogenase catalyzes the reversible oxidative deamination of glutamate to α-ketoglutarate and ammonia. Glutaminase hydrolyzes glutamine to glutamate and ammonia.

  • Aspartate is formed via transamination (from oxaloacetate). This reaction is catalyzed by aspartate aminotransferase (AST).

  • Carbon dioxide (from bicarbonate) and ATP are derived from the surrounding media and are essential for the initial steps of the cycle.

• Outputs:

  • Urea is the main output, disposed of in urine. The kidneys filter urea from the blood, and it is excreted in the urine.

  • Fumarate can pass from the cytosol to the mitochondria as an intermediate in the citric acid cycle or remain in the cytosol to be used in gluconeogenesis. Its role in these pathways allows for metabolic integration.

Energy Production and Consumption

• During the urea cycle, 3 molecules of ATP are consumed, which is equivalent to 4 high-energy bonds. This energy investment is necessary to drive the synthesis of urea.

• Conversion of ATP to AMP releases PPi, which is subsequently hydrolyzed by pyrophosphatase. This hydrolysis is highly exergonic and helps to drive the argininosuccinate synthetase reaction forward.

Urea Cycle and Gluconeogenesis

• The urea cycle normally operates alongside gluconeogenesis as both occur in the liver. This coordinated operation is crucial for metabolic homeostasis.

• Waste nitrogen, supplied to the urea cycle, comes from amino acids, whose carbon skeletons are either oxidized (via CAC to produce carbon dioxide, water, and energy) or used for gluconeogenesis. Thus, amino acid metabolism is tightly linked to both energy production and glucose synthesis.

• The energy from amino acid oxidation is more than enough to fuel ureagenesis and gluconeogenesis. This metabolic coupling ensures that the liver can efficiently detoxify ammonia while maintaining glucose levels.

• Fumarate produced by the urea cycle is hydrated to malate, which is then oxidized to oxaloacetate by cytosolic malate dehydrogenase, generating a reduced NADH in the cytosol. This NADH is important under certain metabolic conditions.

  $\text{Fumarate} \rightarrow \text{Malate} \rightarrow \text{Oxaloacetate}$

• The fate of oxaloacetate is either to produce aspartate via transamination or to be converted to phosphoenolpyruvate (PEP), which is a substrate for gluconeogenesis. These steps allow carbon atoms from amino acids to be incorporated into glucose.

• If gluconeogenesis is underway in the cytosol, the NADH produced by malate dehydrogenase is used to drive the reversal of the glyceraldehyde-3-P dehydrogenase step instead of generating ATP. This ensures efficient glucose production during gluconeogenesis.

Regulation of the Urea Cycle

1. Short-Term Regulation:

   • Occurs principally at carbamoyl phosphate synthetase-I (CPS-I), which is the rate-limiting step of the urea cyle.

   • N-Acetylglutamate (NAG) is an essential allosteric activator for CPSI. Without NAG, CPSI is virtually inactive. NAG effectively modulates the enzyme's affinity for its substrates.

   • N-Acetylglutamate synthase (NAGS) catalyzes the formation of N-Acetylglutamate by the use of acetyl-CoA and glutamate. This regulatory step is critical for coordinating urea cycle activity with amino acid metabolism.

   • N-Acetylglutamate synthase activity is affected by glutamate concentration [GLU] and allosterically activated by arginine. High levels of glutamate and arginine indicate increased amino acid turnover.

   • Temporary increases in amino acid catabolism result in an increase in [GLU] and [arginine]. This signals the need to increase urea production.

   • The resultant increase in [NAG] increases the activity of CPS-I, allowing the urea cycle flux to increase before the [$NH_3$] levels rise. This anticipatory regulation prevents the buildup of toxic ammonia.

   • This type of regulation means that ammonia levels are kept constant, rather than fluctuating along with rates of amino acid catabolism. Thus, the urea cycle responds quickly to changes in amino acid metabolism.

   • The remaining enzymes of the cycle are controlled by the concentrations of their substrates. This ensures that the entire cycle operates efficiently.

2. Long-Term Regulation:

   • Achieved by transcriptional control of the enzymes of the urea cycle and associated transporters. This allows for adaptation to prolonged changes in dietary protein intake or metabolic state.

   • Transcription is largely controlled hormonally. Hormones influence the expression of urea cycle enzymes over longer periods.

   • The main hormones involved in stimulating transcription of urea cycle enzymes are glucagon, adrenaline, and glucocorticoids. These hormones signal a catabolic state.

   • These hormones are involved in managing fasting/starvation or stress situations, where amino acid catabolism is increased. The increased enzyme synthesis helps to cope with the elevated ammonia production.

   • Glucocorticoids also increase toward the end of pregnancy, and glucagon is not expressed until after birth. These hormonal changes prepare the newborn for handling its own waste nitrogen.

   • Insulin may be involved in inhibiting transcription, reflecting its role in promoting anabolism and reducing amino acid catabolism.

Genetic Defects

• Because the human fetus can survive the whole of pregnancy without producing urea, genetic defects in the urea cycle are one of the more common inborn errors of metabolism observed in newborns. This is because the maternal liver handles fetal waste nitrogen.

• Affected infants typically die shortly after birth if not immediately diagnosed and treated. Early diagnosis and intervention are critical for survival.

• Some defects do not show up until much later in life if the enzyme defect is not severe. These milder defects may present during periods of stress or high protein intake.

• Symptoms include hyperammonemia, mental retardation, eventually coma and death. The severity of symptoms varies depending on the specific enzyme affected and the extent of the defect.

• Depending on the enzyme defect, other nitrogenous compounds may accumulate in the blood or urine, providing diagnostic clues. Analysis of these compounds can help identify the specific defect.

1. N-Acetyl Glutamate Synthase (NAGS) Defects:

   • NAGS deficiency mimics CPS deficiency; patients present within the first few days of life with severe hyperammonemia. This is because NAGS is essential for activating CPSI.

   • Patients can be successfully treated with N-carbamyl glutamate, an analog of NAG that can activate CPSI. This treatment bypasses the defective NAGS enzyme.

   • Less severe defects have been reported according to the type of mutation. These patients may present later in life with milder symptoms.

2. Ornithine Transcarbamylase Deficiency:

   • The most common hereditary urea cycle disorder, X-linked and with variable effects. Males are typically more severely affected than females.

   • Excess carbamoyl phosphate feeds into pyrimidine synthesis, leading to a buildup in orotate (useful for diagnosis). Nitrogen also accumulates in glycine and glutamine. This metabolic shunting contributes to the overall metabolic derangement.

   • Treatment: Low protein diet (less ureagenesis is needed). This reduces the amount of ammonia produced. Administration of sodium benzoate and sodium phenylacetate, which conjugate with glycine and glutamine, respectively, and are excreted in the urine, thus providing alternative pathways for nitrogen disposal.

3. Argininosuccinase Deficiency:

   • Results in hyperammonemia, accumulation of argininosuccinate, and arginine becoming an essential amino acid. The block in the urea cycle means that arginine cannot be synthesized de novo.

   • Treatment:

     • Limit protein intake to reduce ammonia production.

     • Add arginine to the diet: The excess arginine is now an essential amino acid that must be obtained in the diet, but it can also fit into the urea cycle and generates ornithine. The accumulated argininosuccinate is excreted in urine. Care must be taken in determining how much is given to the patient. Supplementation with arginine helps drive the cycle forward and provides an alternative route for nitrogen excretion.

Summary

• The urea cycle is a mechanism for preventing ammonia toxicity during amino acid catabolism. It converts toxic ammonia into non-toxic urea, which is then excreted.

• The urea cycle occurs in conjunction with gluconeogenesis, facilitating the coordinated metabolism of amino acids and glucose.

• The urea cycle occurs in the liver but processes waste nitrogen from other sources. The liver is the central organ for nitrogen metabolism.

• Urea cycle activity is modulated in a variety of ways to respond to the changing rates of protein catabolism in different circumstances. The cycle is adaptable to various physiological states.

• Short-term changes in flux are controlled by linking the flux to the rates of amino acid catabolism, rather than to levels of ammonia. This prevents rapid fluctuations in ammonia levels.

• Long-term changes are effected by hormones and involve regulation of transcription. This allows for adaptation to chronic changes in metabolic demand.

• Genetic urea cycle defects are common and can vary in severity. These defects can have significant clinical consequences.

• Treatment can often be given using a knowledge of the urea cycle pathway or other latent pathways. Understanding the biochemical basis of these treatments is essential for effective management.